VG Life Sciences Granted Key Composition of Matter Patent

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
VG Life Sciences Granted Key Composition of Matter Patent

SANTA BARBARA, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc., (OTCQB:VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, announced that the U.S. Patent and Trademark Office (USPTO) has issued an important new composition of matter patent covering methods for modulating immune system function through the targeting of CLIP.

U.S. Patent No. 8957031 covers the targeted peptide technology underlying VG Life Sciences' VG1177, a synthetic peptide which has the ability to displace CLIP (Class II-associated invariant chain peptide) that plays a key role in chronic inflammation and autoimmune diseases, including HIV/AIDS, hypertension, preeclampsia and traumatic brain injury.

"This composition of matter patent is essential to protect and leverage our rich portfolio of intellectual property relating to our promising work targeting CLIP for novel treatments of diseases driven by chronic inflammation," said John Tynan, president and CEO of VG Life Sciences.  

The patent stems from the work of VG Life Sciences Chief Scientific Officer Karen Newell-Rodgers, Ph.D., then at the University of Colorado, along with research by her son, Evan Newell, Ph.D., then at Stanford University. 

CLIP is present on the exterior of cells as part of the body's immune response system. Initially, CLIP plays an essential role in bridging the innate and specific immune responses. When CLIP + cells are not properly depleted, it leads to a chronic inflammatory state that underlies numerous autoimmune diseases. 

Newell-Rogers' work included identifying the amino acid signature of CLIP. This information allowed Newell to identify and synthesize peptides that would have a greater binding affinity than CLIP associated with every known human and animal immune response gene. 

The company's preclinical compound, VG1177, is designed to displace inflammation-causing CLIP. 

"If these cells that are present in the beginning of the inflammatory process can be predictably removed when they are no longer needed, we believe we can suppress disease-causing inflammation," Newell-Rogers said. 

Pre-clinical testing of VG1177 on preeclampsia models showed that it reversed symptoms of high blood pressure, thereby eliminating the dangerous condition. 

Additionally, a paper published last October in the peer-reviewed journal Acta Neuropathologica Communications showed that VG1177 decreased the number of CLIP+ cells and prevented additional damage to the brain after a mild to moderate traumatic injury.

About VG Life Sciences, Inc.

Santa Barbara, California-based VG Life Sciences, Inc., formerly known as Viral Genetics, is a biotechnology company focused on discovering and developing drug therapies for cancer, infectious disease, and inflammatory, autoimmune disorders. VGLS controls over 40 U.S. and international patents and pending patents protecting its exclusive biotech platform technologies. For more information and upcoming events, visit www.vglifesciences.com or find VG Life Sciences, Inc. on Facebook, Twitter, and LinkedIn.

Forward-Looking Statement

This news release may contain forward-looking statements that involve risks and uncertainties associated with financial projections, milestone timelines, clinical development, regulatory approvals and other risks described by VG Life Sciences from time to time in its periodic reports. None of VG Life Sciences' drug compounds are approved by the U.S. FDA or by any comparable regulatory agencies elsewhere in the world. 

Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the forward-looking statements should not be regarded as a representation by VG Life Sciences Inc. or any other person that the objectives and plans of VG Life Sciences will be achieved. 

Media Contact:
Terri Somers, Somers Media
terri@somersmedia.com
619-991-2369

Terri Somers, Somers Media ' 619-991-2369

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 78

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 50

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
Story Cannabis Bets on Neighborly Thanksgiving Outreach

Updated Category News Views 58

A frozen turkey is not a grand strategy deck, thank goodness; it is dinner for a household that might be feeling the squeeze. Story Cannabis plans to hand out 840 of them on Tuesday, Nov. 24, splitting the giveaway between Columbus and Cleveland with former Ohio State and Dallas Cowboys running back Michael Wiley joining employees and volunteers. In a cannabis business...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 65

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 0

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 39

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 116

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 55

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 13

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Arizona's Dry Climate Puts Scalp Health Under Stress

Updated Category News Views 65

Desert weather is unforgiving, and apparently the scalp does not get a pass. In a Nov. 20, 2026 discussion, Scottsdale and Tucson hair-restoration physician Dr. Sharon A. Keene frames Arizona hair concerns around something easy to overlook: the condition of the skin beneath the hair. That is a more sensible starting point than treating every strand in the shower like it...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Circuit Breaker Market Set for Growth Beyond USD 9 Billion

Updated Category News Views 207

Growing Demand for Circuit Breakers in Diverse Industries The circuit breaker market is gearing up for significant growth, projected to reach a remarkable valuation of USD 9.4 billion by 2031. This exciting expansion is largely attributed to the rising demand for electricity and the escalating need for efficient and reliable energy distribution systems. A compound annual...

Continue Reading
Investigation of MoonLake Immunotherapeutics by Law Firm

Updated Category News Views 145

Faruqi & Faruqi's Investigation on Behalf of Investors Faruqi & Faruqi, LLP is actively investigating potential claims for investors of MoonLake Immunotherapeutics (NASDAQ: MLTX). This initiative is aimed at supporting those who have experienced financial losses and educating them about their legal options. Investors affected are encouraged to reach out to the firm's...

Continue Reading
Golden Ocean Group Limited Announces Q2 2024 Results

Updated Category News Views 92

Golden Ocean Group Limited Reports Q2 2024 Financial Results Hamilton, Bermuda – Golden Ocean Group Limited (NASDAQ/OSE: GOGL), recognized as the largest publicly traded owner of large dry bulk vessels, has released its unaudited financial results for the quarter ending June 30, 2024. Financial Highlights In the second quarter of 2024, Golden Ocean achieved a net income...

Continue Reading
Georgia Dental Association Boosts Access to Teledentistry

Updated Category News Views 215

Expanding Access to Oral Health Care in Georgia Governor Signs Milestone Teledentistry Bill into Law Recently, a significant milestone for dental care was achieved with the signing of House Bill 567, aimed at enhancing access to oral health care through teledentistry. This new legislation, advanced by the Georgia Dental Association, is designed to remove barriers that...

Continue Reading
Anticipated Growth in Economic Indicators for Upcoming GDP

Updated Category News Views 132

Anticipated Growth in Economic Indicators for Upcoming GDP The second-quarter GDP report is set to reveal noteworthy developments in the U.S. economy, signaling a moderate recovery in output. Recent estimates, compiled from various nowcasts, suggest an anticipated growth of 1.7% in GDP for this period. Current Economic Outlook This projection remains steady from earlier...

Continue Reading